Tilki, Derya
Derya Tilki researcher
Tilki, Derya 1979-
VIAF ID: 74989427 (Personal)
Permalink: http://viaf.org/viaf/74989427
Preferred Forms
- 100 0 _ ‡a Derya Tilki ‡c researcher
- 100 1 _ ‡a Tilki, Derya
- 100 1 _ ‡a Tilki, Derya ‡d 1979-
4xx's: Alternate Name Forms (1)
5xx's: Related Names (2)
Works
Title | Sources |
---|---|
Bladder cancer stage and mortality: urban vs. rural residency | |
Correlation of MRI-lesion targeted biopsy vs. systematic biopsy gleason score with final pathologicalg gleason score after radical prostatectomy | |
Correlation of urine loss after catheter removal and early continence in men undergoing radical prostatectomy | |
Duale Rolle von CEACAM1 bei der Angiogenese und der Tumorinvasion am Beispiel des Harnblasen- und Prostatakarzinoms | |
Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups | |
Einfluss der bilateralen Schonung der neurovaskulären Bündel in Bezug auf das onkologische Ergebnis bei Patienten mit fortgeschrittenem Prostatakarzinom | |
Full functional-length urethral sphincter- and neurovascular bundle preservation improves long-term continence rates after robotic-assisted radical prostatectomy | |
Heterogenität innerhalb der D'Amico-Klassifikation beim Prostatakarzinom mit geringem Risiko Unterschiede im upgrading und upstaging der Active Surveillance-Eignung | |
Immunohistochemistry for prostate biopsy - impact on histological prostate cancer diagnoses and clinical decision making | |
Influence of tumor burden on serum prostate-specific antigen in prostate cancer patients undergoing radical prostatectomy | |
Long-term overall survival of radical prostatectomy patients is often superior to the general population: A comparison using life-table data | |
Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancer | |
Non-organ confined stage and upgrading rates in exclusive PSA high-risk prostate cancer patients | |
Outcomes of robotic-assisted versus open radical cystectomy in a large-scale, contemporary cohort of bladder cancer patients | |
Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis | |
Radiation therapy after radical prostatectomy: what has changed over time? | |
radikale Prostatektomie mit neoadjuvanter Androgendeprivationstherapie (NHT) für das lokal fortgeschrittene cT4cN0-1cM0 Prostatakarzinom mit Infiltration von Harnblase und/oder Rektum | |
Survival rates with external beam radiation therapy in newly diagnosed elderly metastatic prostate cancer patients | |
Tumor Characteristics and Oncological Outcome after Radical Prostatectomy in Men 75 Years and Older | |
Tumorcharakteristika und onkologisches Outcome nach radikaler Prostatektomie bei Männern ab dem 75. Lebensjahr | |
Twenty-year trends in prostate cancer stage and grade migration in a large contemporary german radical prostatectomy cohort | |
Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer |